Matches in Nanopublications for { ?s ?p "[Homozygous deletion, a combination of LOH and promoter hypermethylation, and multiple LOH are major mechanisms of p16 inactivation in gallbladder cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP184769.RAWp--76zDaRaf1QOv7rAN5imY_9pEFhBcKsS-_WXN_C8130_assertion description "[Homozygous deletion, a combination of LOH and promoter hypermethylation, and multiple LOH are major mechanisms of p16 inactivation in gallbladder cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP184769.RAWp--76zDaRaf1QOv7rAN5imY_9pEFhBcKsS-_WXN_C8130_provenance.
- NP145786.RAUReA_20Wx2bb3lAARtQoBeCQ0ylDAejNcAdgi7DqKso130_assertion description "[Homozygous deletion, a combination of LOH and promoter hypermethylation, and multiple LOH are major mechanisms of p16 inactivation in gallbladder cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP145786.RAUReA_20Wx2bb3lAARtQoBeCQ0ylDAejNcAdgi7DqKso130_provenance.
- NP207424.RAgtiwl8DozhPUQax03WtbZuT_S_hpERldXkaydDb0ZFg130_assertion description "[Homozygous deletion, a combination of LOH and promoter hypermethylation, and multiple LOH are major mechanisms of p16 inactivation in gallbladder cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP207424.RAgtiwl8DozhPUQax03WtbZuT_S_hpERldXkaydDb0ZFg130_provenance.
- assertion description "[Homozygous deletion, a combination of LOH and promoter hypermethylation, and multiple LOH are major mechanisms of p16 inactivation in gallbladder cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP208926.RAx9n2He_LFEqklMGSYQhcsdNyGpFK0ZUAROrPcoeKjcA130_assertion description "[Homozygous deletion, a combination of LOH and promoter hypermethylation, and multiple LOH are major mechanisms of p16 inactivation in gallbladder cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP208926.RAx9n2He_LFEqklMGSYQhcsdNyGpFK0ZUAROrPcoeKjcA130_provenance.
- NP232268.RA_AvYNHuRRisZyiKhIoMzvLdZil3i0bH_me_O9ajRCKw130_assertion description "[Homozygous deletion, a combination of LOH and promoter hypermethylation, and multiple LOH are major mechanisms of p16 inactivation in gallbladder cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP232268.RA_AvYNHuRRisZyiKhIoMzvLdZil3i0bH_me_O9ajRCKw130_provenance.